Q1 FY27 Results: Strong Growth in Revenue & Profit
Tatva Chintan Pharma Chem Limited · TATVA · NSE ·
• The company has published its unaudited financial results for the quarter ended June 30, 2026 (Q1 FY27). • **Total Income from Operations (Consolidated):** ₹11,947.87 Lakhs, a growth of 9.70% year-over-year. • **Net Profit After Tax (Consolidated):** ₹1,501.34 Lakhs, an increas…